Home Care Testing Market – By Product Type (Strip, Cassette, Test Panel, Midstream, Dip Card), Test Type (Infectious Disease, Diabetes & Glucose, HIV Pregnancy, Cholesterol & Triglycerides, UTI), Sample (Blood), Distribution Channel & Forecast, 2024 - 2032

Home Care Testing Market Size

Home care testing market size was valued at around USD 10.9 billion in 2023 and is estimated to grow at 6.8% CAGR from 2024 to 2032. The rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders is a significant driver for the growth of the market.
 

For instance, according to the International Diabetes Federation, the global prevalence of diabetes in 2021 was estimated to be 10.5%, affecting approximately 536 million adults. With chronic conditions requiring regular monitoring, patients are increasingly turning to home care testing solutions for convenience and timely management of their health. These at-home tests offer a practical alternative to frequent visits to healthcare facilities, reducing healthcare costs and improving patient compliance.
 

Home care testing refers to a range of medical tests and diagnostic procedures that individuals can perform at home, rather than in a clinical setting. These tests are designed to be user-friendly, allowing individuals to monitor various health parameters and manage chronic conditions conveniently and efficiently.
 

Home Care Testing Market Trends

Recent technological advancements in home care testing are revolutionizing patient monitoring and health management, driving increased demand and usage.
 

• Innovations such as digital health platforms, wearable medical devices, and mobile apps enable real-time health monitoring and data sharing with healthcare providers, enhancing patient care and management. These technologies provide greater accuracy and convenience, making home testing more reliable and accessible.
   
• For instance, continuous glucose monitors (CGMs) offer real-time blood sugar readings and integrate seamlessly with smartphones. These self-monitoring blood glucose devices allowing users to track their levels and receive alerts instantly.
   
• Similarly, at-home diagnostic kits for COVID-19, equipped with smartphone apps, provide quick and accurate results, reducing the need for lab visits and ensuring timely intervention.
   
• Additionally, the development of smart home healthcare devices by leveraging advanced technologies such as artificial intelligence (AI) and machine learning to provide more accurate and personalized health insights.
   
• For instance, smart blood pressure monitors with AI-driven algorithms, not only measure blood pressure but also analyze trends and provide health recommendations based on the user's historical data.
   
• Additionally, electrocardiogram devices can detect irregular heart rhythms and other cardiac issues, sending detailed reports directly to healthcare providers for immediate review and action. These innovations are enhancing the efficacy and user experience of home care testing, making it a vital component of modern healthcare.
   

Home Care Testing Market Analysis

Based on product type, the market is categorized into strip, cassette, test panel, midstream, dip card, and other product types. The strip segment dominated the market, with a revenue share of around 25.8% in 2023.
 

• Strip-based tests are versatile and can be used for a wide range of applications, including pregnancy testing, monitoring blood glucose levels in diabetes, and testing for various infections or substances in urine. This versatility makes them appealing to a broad range of consumers with different healthcare needs?.
   
• Additionally, strip tests are often more affordable compared to other types of home testing formats, making them accessible to a larger portion of the population, including those with limited financial resources, resulted in their increased demand.
   

Based on test type, the home care testing market is categorized into infectious disease, diabetes & glucose, HIV, pregnancy, cholesterol & triglycerides, urinary tract infection, and other test types. The infectious disease segment is anticipated to witness highest growth with USD 5.2 billion in 2032.
 

• Rapid home testing kits for infectious diseases provide quick results, allowing individuals to receive timely information about their health status. This is crucial for early detection and containment of infectious diseases.
   
• Additionally, integration with telehealth services allows individuals to consult healthcare professionals remotely, further enhancing the value of home testing for infectious diseases. Hence these factors contributed to the segmental growth.
   

Based on sample, the home care testing market is categorized into blood, urine, saliva, and other samples. The blood segment dominated the market, with a revenue share of 40.7% in 2023.
 

• Blood samples are used for a wide range of diagnostic tests, including glucose monitoring for diabetes, cholesterol testing, infectious disease screening, and hormone level assessments, among others. This broad applicability makes blood-based home testing kits relevant to a large segment of the population.
   
• Additionally, blood-based tests are often considered more clinically accurate compared to other sample types. This accuracy is crucial for medical conditions that require precise measurement and monitoring, further driving the demand for blood-based home testing kits.

Based on distribution channel, the home care testing market is categorized into retail pharmacies, hospital pharmacies, online pharmacies and other distribution channel. The retail pharmacies segment dominated the market, with a revenue share of around 39.1% in 2023.
 

• Retail pharmacies have a wide network of outlets, making them easily accessible to a large population, including individuals seeking home care testing solutions.
   
• Additionally, retail pharmacies generally maintain sufficient inventory levels of home care testing kits, ensuring that products are readily available for purchase. This immediate availability meets the needs of consumers who require testing kits on short notice or prefer to obtain them without delay.

North America home care testing market accounted for USD 4.9 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The increasing incidence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions necessitates regular monitoring, which home care testing effectively facilitates. For instance, the American Diabetes Association reports that over 34 million Americans have diabetes, driving the demand for home glucose monitoring.
   
• Additionally, North America is at the forefront of technological advancements, with the development of sophisticated home testing devices, which increases their demand in the region.
   

U.S. home care testing market holds a dominant position with the market share of 93.8% in 2023.  
 

• The U.S. Food and Drug Administration (FDA) has approved a growing number of home testing kits, providing consumers with assurance regarding safety and reliability.
   
• Additionally, government and public health initiatives in the U.S. promote preventive care and early detection, aligning with the goals of home testing for chronic conditions and infectious diseases, increased their demand in the country.
   

Germany home care testing market is expected to grow significantly during the forecast period.
 

• There is a growing emphasis on preventive healthcare in Germany, with individuals increasingly interested in monitoring their health proactively through home testing.
   
• Additionally, home testing addresses issues of healthcare accessibility, particularly in rural or remote areas of Germany where access to healthcare facilities may be limited. Hence contributes to the market growth in Germany.
   

China home care testing market is anticipated to witness a high growth rate from 2024-2032, due to several factors.
 

• As China economy continues to grow, there has been an increase in healthcare spending, driving demand for convenient and affordable healthcare solutions like home testing.
   
• Additionally, the Chinese government has been promoting preventive healthcare and encouraging innovation in the healthcare sector, which includes support for home testing technologies.
   

Home Care Testing Market Share

The home care testing industry is competitive in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel home care products with improved efficiency and cost-effectiveness are key market strategies for home care testing product manufacturers, driving competition and innovation in the industry. This emphasis on innovation aims to address evolving clinical needs and enhance patient outcomes, positioning companies to gain market share and meet the growing demand for novel home care testing.
 

Home Care Testing Market Companies

Some of the eminent market participants operating in the home care testing industry include:

• Abbott
• ACON Laboratories, Inc.
• Ascensia Diabetes Care Holdings AG
• BD
• bioLytical Laboratories Inc.
• BioSure
• Cardinal Health
• Chembio Diagnostics, Inc
• F. Hoffmann-La Roche Ltd.
• LifeScan IP Holdings, LLC
• MP BIOMEDICALS 
• Nova Biomedical
• OraSure Technologies, Inc.
• Quidel Corp.
• SA Scientific Ltd
• Siemens Healthcare GmbH
• Sterilab Services
   

Home Care Testing Industry News:

• In November 2023, ACON Laboratories, Inc. received FDA 510(k) marketing clearance for its Flowflex COVID-19 Antigen Home Test. This approval expanded the company market reach and improved its positioning in the homecare testing market. 
   
• In Aprile 2022, bioLytical Laboratories Inc. announced the launch of iStatis COVID-19 Antigen Home Test after receiving Health Canada Interim Order authorization, allowing its immediate entry into the Canadian market. This launch improved the company market reach and enhanced its customer base.
   

Home care testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

                                                 

Market, By Product Type

• Strip
• Cassette
• Test panel
• Midstream
• Dip card
• Other product types

Market, By Test Type

• Infectious disease
• Diabetes & glucose
• HIV
• Pregnancy
• Cholesterol & triglycerides
• Urinary tract infection
• Other test types

Market, By Sample  

• Blood
• Urine
• Saliva
• Other samples

Market, By Distribution Channel

• Retail pharmacies
• Hospital pharmacies
• Online pharmacies
• Other distrbution channels

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa